Cargando…
Evolution of drug regulations and regulatory innovation for anticancer drugs in China
Over the past two decades, China has introduced significant changes to drug regulations through regulatory innovations to accelerate drug review and approvals, keeping in line with the rapidly growing scientific innovation in drug research and development (R&D). In this study, we outlined the re...
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764065/ https://www.ncbi.nlm.nih.gov/pubmed/36561995 http://dx.doi.org/10.1016/j.apsb.2022.08.004 |